Health Technology · Pharmaceuticals: Major · NSE: BMLL · data 2026-10-09
Bio Medica Laboratories Limited
Health check: Strong (8.6/10 on quality, valuation vs sector, growth and momentum).
Open full analysis — chart, results, balance sheet, red flags →Key figures
Price
₹153
Market cap
—
P/E
—
P/B
—
ROE
57.1%
ROCE
48.5%
Debt / equity
1.51
Dividend yield
—
1-year return
37.6%
52-week high
₹181
52-week low
₹101.5
Operating margin
—
Growth
| Revenue (last 12 months) | — |
| Net profit (last 12 months) | — |
| Sales growth, 3 years (yearly) | 38.5% |
| Profit growth, 3 years (yearly) | 228.1% |
Similar companies
Medicamen Organics Ltd. (MEDIORG) · Medi-Caps Ltd. (MEDICAPQ) · Lasa Supergenerics Ltd. (LASA) · Sunrest Lifescience Limited (SUNREST) · Ortin Global Ltd (ORTINGLOBE)
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open BMLL in NSE Scanner →